Home injection
 

Keywords :   


Tag: injection

Grease Injection Pump operates at up to 10,000 psi.

2016-02-18 14:31:06| Industrial Newsroom - All News for Today

Providing quiet, smooth operation, High-Pressure Hydraulic Dyna-Star® Pump is suited for wireline, slickline, and wire rope applications. Unit is proven to reach up to 10,000 psi in field, and dramatically reduces freezing, stopping, and stalling. In addition, pump is self-lubricating, minimizing need for maintenance. It is suitable for oil and gas well services, as well as for preventing internal corrosion in wire rope applications.

Tags: operates pump injection psi

 

Needleless Injection Site has non-disconnect male luer lock.

2016-02-18 14:31:06| Industrial Newsroom - All News for Today

Made of COC (cyclic olefin copolymer) external body, polycarbonate internal body, and latex-free silicone valve, needleless injection site (No. 91600) is EtO and Gamma sterilization compatible. Non-disconnect male luer lock provides non-removable connection and thereby eliminates need for bonding. Also, connector features swabbable luer activated female luer lock for aspiration or injection.

Tags: site male lock injection

 
 

FDA Approves Mercks Single-Dose EMEND (fosaprepitant dimeglumine) for Injection, in Combination with Other Antiemetic Agents, for the Prevention of Delayed Nausea and Vomiting in Adults Receiving Moderately Emetogenic Chemotherapy (MEC)

2016-02-04 14:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. First and Only Intravenous NK1 Receptor Antagonist Approved in the U.S. for Use in MEC KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for single-dose EMEND (fosaprepitant dimeglumine) for injection, Mercks substance P/neurokinin-1 (NK1) receptor antagonist, in combination with other antiemetic medicines, for the prevention of delayed nausea and vomiting in adults receiving initial and repeat courses of moderately emetogenic chemotherapy (MEC). Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: combination agents receiving adults

 

Hacklet 93 - Robotics Toolkit and ESP8266 Packet Injection

2016-01-31 05:30:07| Wireless - Topix.net

You never know where a hack will take you. Sometimes a simple project will take on a life of its own and become a huge software framework.

Tags: injection toolkit packet robotics

 

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

2016-01-23 07:38:52| Biotech - Topix.net

Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha Injection, the first proprotein convertase subtilisin/kexin type 9 inhibitor to be approved in Japan. Repatha is a human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol , or "bad" cholesterol, from the blood.

Tags: japan approval injection announces

 

Sites : [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] next »